HealthEquity Inc HQY

DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that Noémie Heuland, Chief Financial Officer of Moody’s Corporation (NYSE: MCO), has been elected to its board of directors (the “Board”) effective Sept. 24, 2026. Heuland will also serve on the Audit and Risk Committee and Cybersecurit

HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.

HealthEquity (NASDAQ:HQY) posted second-quarter fiscal 2027 results on August 27, which pushed revenue growth to 8% year over year, up from the 7% pace set over the first half of the year, a rare acceleration for a company already sitting on 10.7 million health savings accounts/HSAs. Adjusted EBITDA jumped 11% to $167 million, translating into […]

HealthEquity (HQY) is back in focus after reporting second quarter results on 27 August 2026, along with higher full year guidance, a completed share repurchase tranche and a new employee stock plan related shelf registration. Despite the strong Q2 update and raised full year guidance, HealthEquity’s share price has pulled back sharply in the very short term, with a 1 day share price return of down 10.6% and a 7 day return of down 10.4%. That sits against a 90 day share price return of 6.1%...

HealthEquity stock has delivered a solid 5 year gain, yet current valuation checks send a mixed message as the Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable discount while market based multiples look stretched. Recent share price weakness adds another layer, since the broader value score does not clearly classify the stock as either cheap or expensive. HealthEquity has returned 41.2% over 5 years, which suggests the longer term holders have still come out ahead...

HealthEquity Inc (HQY) delivers record Q2 results with 8% revenue growth and a 48% adjusted EBITDA margin, fueled by AI-driven efficiencies and strong HSA member engagement.

Moby summary of HealthEquity, Inc.'s Q2 2027 earnings call

HealthEquity’s second-quarter results combined higher revenue and earnings with record HSA accounts, assets and Adjusted EBITDA margin, prompting management to increase its full-year outlook. Key Investor TakeawaysHealthEquity (NASDAQ:HQY) raised fiscal 2027 guidance after second-quarter revenue increased 8% year over year to $350.

Highlights of the second quarter include: Net income increased 10% to $65.6 million, and net income margin increased to 19% from 18% last year.Adjusted EBITDA increased 11% to $167.0 million, and Adjusted EBITDA margin increased to 48% from 46% last year.Revenue increased 8% to $350.7 million.Net income per diluted share rose 15% to $0.78 from $0.68 one year ago, and non-GAAP net income per diluted share increased 15% to $1.24.Total HSA Assets grew 14% to $37.9 billion.Returned $108.1 million to